Company Ikaria, Inc.

Equities

IKAR

US45173V1070

Pharmaceuticals

End-of-day quote Nasdaq 5-day change 1st Jan Change
- USD -.--% Intraday chart for Ikaria, Inc. -.--% -.--%

Business Summary

Ikaria, Inc. is a United States-based company. The Company operates as a biotherapeutics company focused on developing and commercializing therapeutics for critical care. Its INOtherapy is an offering of drug product, services and technologies. Its product INOtherapy includes INOMAX, which is an treatment for hypoxic respiratory failure in term and near-term infants.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,926,630 0 0 -

Company contact information

Ikaria, Inc.

Perryville III Corporate Park 53 Frontage Road

08827, Hampton

+908 238 6600

http://ikaria.com
address Ikaria, Inc.(IKAR)